Summary of Classification and Labelling
Notified classification and labelling
General Information
807-012-2 |
Pembrolizumab |
1374853-91-4 |
Notified classification and labelling according to CLP criteria
Repr. 1B |
H360
(H360D: May dama...)
|
H360
(H360D: May dama...)
|
|
GHS08 Dgr
|
|
|
|
|
35 |
|
View details
|
STOT RE 1 |
H372
(Damage to organ...)
|
H372
|
Repr. 1B |
H360
(H360D: May dama...)
|
H360
|
|
GHS08 Dgr
|
|
|
|
|
1 |
|
View details
|
STOT RE 1 |
H372
(Damage to organ...)
|
H372
|
Number of Aggregated Notifications: 2